Mumbai: Pharma Firm, Alembic Pharmaceuticals (Alembic Pharma) has sold its formulations manufacturing facility at Baddi to Scott Edil Pharmacia (SEPL), the company said in a filing to the bourses on Wednesday.
SEPL does not belong to the promoter or promoter group or group companies and is not a related party of the company. The turnover and net worth of the said manufacturing facility for the last financial year vis-à-vis turnover and net worth of the company is insignificant, the company added.
The company continues to meet its domestic formulation demand from Sikkim Unit and international formulation demand from its Panelav Unit. Alembic Pharmaceuticals is engaged developing formulations and active pharmaceutical ingredients (API).
The company focuses on anti-infective, analgesic and cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynaecology, gastrointestinal, orthopedic, dermatology, and ophthalmology.